← Leaderboards
Susan M Majka
National Jewish Health
$13,999,914
Attributed
$15,199,324
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,199,324 · 9
By mechanism
R01$10,432,941 · 4
R35$3,964,079 · 1
R21$422,175 · 1
R56$336,200 · 1
F32$33,929 · 1
R13$10,000 · 1
Top collaborators
- Richard Lee Reinhardt4 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Stijn Piet Johan De Langhe$10,419,756
- Julita A Ramirez$400,115
- William Janssen$11,441,179
- Andrew H Liu$4,764,663
- Monica Kraft$36,612,836
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultCellsIn VivoStructureLungBlood VesselsLung DiseasesIn VitroTissuesSignal TransductionHomeostasisVascular DiseasesMesenchymalFunctional DisorderPulmonary EmphysemaAffectMouse ModelPhenotypeStem CellsRegulationProgenitorCell PhysiologyMaintenanceStructure Of Parenchyma Of Lung
Grant awards (29)
Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema$996,000
R35 · FY2025 · HL · contact PI
Loss of progenitor function accelerates lung aging$672,911
R01 · FY2025 · AG · contact PI
2025 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2025 · HL · contact PI
Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema$976,079
R35 · FY2024 · HL · contact PI
Loss of progenitor function accelerates lung aging$691,090
R01 · FY2024 · AG · contact PI
Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema$996,000
R35 · FY2023 · HL · contact PI
Loss of progenitor function accelerates lung aging$698,619
R01 · FY2023 · AG · contact PI
Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema$996,000
R35 · FY2022 · HL · contact PI
Role of Lung MSC in Emphysema$616,754
R01 · FY2021 · HL · contact PI
Lung MSC regulate angiogenesis and repair during fibrosis$611,477
R01 · FY2021 · HL · contact PI
Loss of progenitor function accelerates lung aging$336,200
R56 · FY2021 · AG · contact PI
Role of Lung MSC in Emphysema$616,754
R01 · FY2020 · HL · contact PI
Lung MSC regulate angiogenesis and repair during fibrosis$611,477
R01 · FY2020 · HL · contact PI
Role of Lung MSC in Emphysema$632,895
R01 · FY2019 · HL · contact PI
Lung MSC regulate angiogenesis and repair during fibrosis$626,238
R01 · FY2019 · HL · contact PI
Role of Lung MSC in Emphysema$615,833
R01 · FY2018 · HL · contact PI
Lung MSC regulate angiogenesis and repair during fibrosis$605,176
R01 · FY2018 · HL · contact PI
Role of Lung MSC in Emphysema$486,115
R01 · FY2016 · HL · contact PI
Role of Lung MSC in Emphysema$473,673
R01 · FY2015 · HL · contact PI
Role of Lung MSC in Emphysema$471,270
R01 · FY2014 · HL · contact PI
Role of Lung MSC in Emphysema$518,687
R01 · FY2013 · HL · contact PI
Induced pluripotent stem cell therapy for lipodystrophy$188,175
R21 · FY2013 · DK · contact PI
Fate of Lung Stem Cells During Pulmonary Disease$367,502
R01 · FY2012 · HL · contact PI
Induced pluripotent stem cell therapy for lipodystrophy$234,000
R21 · FY2012 · DK · contact PI
Fate of Lung Stem Cells During Pulmonary Disease$417
R01 · FY2012 · HL · contact PI
Fate of Lung Stem Cells During Pulmonary Disease$371,635
R01 · FY2011 · HL · contact PI
Fate of Lung Stem Cells During Pulmonary Disease$371,635
R01 · FY2010 · HL · contact PI
Fate of Lung Stem Cells During Pulmonary Disease$372,783
R01 · FY2009 · HL · contact PI
Skeletal Muscle Stem Cells Become Vascular Cells In Vivo$33,929
F32 · FY2001 · HL